Topic resource collection
Approved comparison material connected to this topic.
23 resourcesRead both sides
Long R3 IGF-1 vs IGF-1 LR3 — Same Peptide Explained Long R3 IGF-1 and IGF-1 LR3 are identical research peptides with the same modified amino acid sequence and extended half-life for lab studies. Research labs ordering peptides fo…
FOXO4-DRI Disrupts FOXO4-p53 binding in senescent cells, releasing p53 to trigger apoptosis High (targets FOXO4-p53 complex unique to senescent cells) None. Preclinical rodent studies only Subcutaneous injection Lyophilized: −20°…
Evidence-based statements are narrow: Prostamax has been studied in lymphocyte chromatin experiments, rat prostatitis models, and patent-described prostate applications [2], [3], [4], [20]. Speculative statements include broad cl…
Reported Prostamax side effects are difficult to summarize because published human adverse-event data are sparse. Patent material describes animal toxicity testing and broad tolerability claims, but patent safety descriptions are…
Commonly cited protocol ranges for Prostamax found online are not evidence-based unless they trace back to a reliable study, regulated label, or clinician-reviewed protocol for a specific patient. For Prostamax, approved-label do…
Research labs ordering peptides for the first time often waste hours verifying whether Long R3 IGF-1 and IGF-1 LR3 are different compounds. They're not. Both names refer to the same synthetic analog of insulin-like growth factor-…
Amino Acid Length 83 residues 70 residues The 13-residue N-terminal extension in Long R3 is the primary structural modification. Not a post-translational addition but a designed sequence extension Position 3 Residue Arginine (Arg…
This table compares FPF 1070 against structurally related peptides commonly used in metabolic research. Understanding these differences helps researchers select the appropriate compound for specific experimental designs. FPF 1070…
Melanocortin-derived peptides share overlapping receptor targets but differ significantly in selectivity, potency, and safety profiles. Understanding where ACTH(4-7)-PGP fits within this family clarifies its niche. ACTH(4-7)-PGP …
TP-7 is used across multiple research domains, each leveraging its immune-modulatory mechanism in different experimental contexts. The table below compares TP-7 to related peptides used in immune research, highlighting primary me…
PE occupies a unique position in the peptide research landscape because it demonstrates both neurogenic and neuroprotective properties through the same mechanism. Understanding the distinction—and overlap—between these two effect…
SLU PP332 ERRα agonist. Mitochondrial biogenesis Skeletal muscle, brown adipose tissue, cardiac muscle Increases oxidative capacity and fat oxidation without reducing ATP efficiency None. Does not affect satiety hormones or gastr…
The metabolic peptide landscape includes dozens of compounds targeting different mechanisms. GLP-1 receptor agonists like semaglutide reduce appetite through hypothalamic signaling, AMPK activators like 5-Amino-1MQ shift cellular…
The table below clarifies nomenclature, mechanism, and evidence quality for what remains a single peptide despite varied naming conventions. Chemical Identity Nonapeptide: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu Identical molecule. A…
SLU PP332 same as SS-LUP-332 is frequently compared to 2,4-dinitrophenol (DNP), the industrial chemical infamous for causing fatal hyperthermia when misused as a weight-loss agent. Both are mitochondrial uncouplers, but their saf…
Mechanism Mitochondrial uncoupling via pH-sensitive proton transport Non-selective mitochondrial uncoupling GLP-1 receptor agonism (appetite suppression, delayed gastric emptying) SLU PP332 increases energy expenditure without ap…
The following table compares how both naming conventions appear across different research contexts and what each context requires for experimental validity. In vitro enzyme assays (recombinant NNMT) 5-Amino-1MQ (systematic) 0.1–1…
The pharmaceutical sleep aid market relies primarily on three drug classes: benzodiazepines (e.g., temazepam), Z-drugs (e.g., zolpidem), and melatonin receptor agonists (e.g., ramelteon). Each operates through distinct mechanisms…
ARA290 Tissue protection via innate repair receptor activation; anti-apoptotic and anti-inflammatory signaling CD131-EPO receptor heterodimer (IRR) Phase II RCTs in diabetic neuropathy and sarcoidosis; 58% responder rate for 30% …
Researchers selecting anti-inflammatory peptides for immune modulation studies face multiple options beyond native VIP, each with distinct pharmacokinetic profiles and receptor selectivity patterns. Native VIP ~2 minutes VPAC1/VP…